Buxue Tiaojing Tablets
Natural health product licensed in Canada
- Licence holder
- Classical Remedia Ltd.
- NPN or DIN-HM
- 80007449
- Status
- Active licence
- Licence date
- 5 September 2008
- Revision date
- 26 May 2010
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rhodomyrtus tomentosa Source : Fruit(s) mûr(s) Extraction ratio : 13.84:1 Dry plant equivalent : 300 mg | 21.67 mg | Not calculated |
| Spatholobus suberectus Source : Tige(s) Extraction ratio : 11.25:1 Dry plant equivalent : 300 mg | 26.67 mg | Not calculated |
| Atractylodes lancea Source : Rhizome(s) Extraction ratio : 10.29:1 Dry plant equivalent : 72 mg | 7 mg | Not calculated |
| Alpinia officinarum Source : Rhizome(s) Extraction ratio : 15:1 Dry plant equivalent : 210 mg | 14 mg | Not calculated |
| Capsella bursa-pastoris Source : Parties aériennes Extraction ratio : 9.23:1 Dry plant equivalent : 120 mg | 13 mg | Not calculated |
| Rosa laevigata Source : Fruit(s) Extraction ratio : 9.08:1 Dry plant equivalent : 300 mg | 33.02 mg | Not calculated |
| Mallotus apelta Source : Feuille(s) Extraction ratio : 11.25:1 Dry plant equivalent : 150 mg | 13.33 mg | Not calculated |
| Cinnamomum cassia Source : Écorce Extraction ratio : 1.02:1 Dry plant equivalent : 15 mg | 14.67 mg | Not calculated |
| Cinnamomum cassia Source : Tige(s) Extraction ratio : 1.02:1 Dry plant equivalent : 15 mg | 14.67 mg | Not calculated |
| Taxillus chinensis Source : Branche(s) Extraction ratio : 14.15:1 Dry plant equivalent : 300 mg | 20.67 mg | Not calculated |
| Taxillus chinensis Source : Feuille(s) Extraction ratio : 14.15:1 Dry plant equivalent : 300 mg | 20.67 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Ponceau 4R, Talc, Amidon de maïs, Saccharose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Traditional Chinese medicine to nourish the blood and regulate the Qi (vital energy) to help relieve complaints such as pallor (paleness), leucorrhea and menstrual cramps.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80007449
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed. Photograph the packaging